Listed
Stock Code: 246710
| Company Name | (주)티앤알바이오팹 |
| English Name | T&R Biofab Co., Ltd |
| Business Reg. No. | 1408173187 |
| CEO | 윤원수 |
| Address | 경기도 시흥시 마유로 96 - |
| Industry | 그 외 기타 분류 안된 화학제품 제조업 |
| Industry Code | 211 |
| Established | 2013-03-11 |
| Phone | 031-431-3344 |
| Website | www.tnrbiofab.com |
| Regular Employees | 83persons |
| Corp. Reg. No. | 1355110249041 |
Venture Certified
| 기술평가보증기업(기금) | 2014-05-08 ~ 2016-05-07 | 20140105349 | 2014-05-08 |
| 벤처투자유형 | 2016-07-04 ~ 2018-07-03 | 20160300321 | 2014-05-08 |
| 벤처투자유형 | 2018-07-04 ~ 2020-07-03 | 20180300490 | 2014-05-08 |
| 벤처투자유형 | 2020-07-04 ~ 2022-07-03 | 20200300726 | 2014-05-08 |
| 벤처투자유형 | 2022-07-04 ~ 2025-07-03 | 20220622010013 | 2014-05-08 |
| 벤처투자유형 | 2025-07-04 ~ 2028-07-03 | 20250717010001 | 2014-05-08 |
Revenue CAGR -8.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 49B | 52B | 58B |
| Operating Profit | -133B | -127B | -129B |
| Net Profit | -110B | -134B | -103B |
| Total Assets | 755B | 998B | 759B |
| Total Liabilities | 546B | 686B | 367B |
| Total Equity | 209B | 312B | 393B |
Operating Loss: Op. profit -133B
3 Consecutive Years of Net Loss
▼ 11.0%
▼ 3.8%
▼ 16.4%
▲ 66.4%
▼ 51.0%
| Name | Position | Role |
|---|---|---|
| 윤원수 | 대표이사 | 대표 |
| NPS Subscribers | 83persons |
| CEO | 윤원수 |
| Est. Avg. Annual Salary | 4,95310K (41310K/mo) |
| Hired (12 mo) | +5persons |
| Left (12 mo) | -3persons |
| Net Change (12 mo) | +2persons |
| NPS Join Date | 2013-05-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "경기 시흥시",
"ceo_name": "윤원수",
"certificate": [
{
"cert_number": "20140105349",
"changes": "",
"disclosure_date": "2014-05-08",
"first_cert_date": "2014-05-08",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-05-08 ~ 2016-05-07"
},
{
"cert_number": "20160300321",
"changes": "",
"disclosure_date": "2016-07-04",
"first_cert_date": "2014-05-08",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2016-07-04 ~ 2018-07-03"
},
{
"cert_number": "20180300490",
"changes": "",
"disclosure_date": "2018-07-12",
"first_cert_date": "2014-05-08",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2018-07-04 ~ 2020-07-03"
},
{
"cert_number": "20200300726",
"changes": "",
"disclosure_date": "2020-06-18",
"first_cert_date": "2014-05-08",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2020-07-04 ~ 2022-07-03"
},
{
"cert_number": "20220622010013",
"changes": "",
"disclosure_date": "2022-06-22",
"first_cert_date": "2014-05-08",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2022-07-04 ~ 2025-07-03"
},
{
"cert_number": "20250717010001",
"changes": "",
"disclosure_date": "2025-07-17",
"first_cert_date": "2014-05-08",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2025-07-04 ~ 2028-07-03"
}
],
"company_name": "(주)티앤알바이오팹",
"financials": {
"2022": {
"capital_stock": 10597209000,
"cost_of_sales": 4212918000,
"current_assets": 46834503000,
"current_liabilities": 29102440000,
"gross_profit": 1541728000,
"net_income": -10337052000,
"net_income_bs": -10337052000,
"non_current_assets": 29103353000,
"non_current_liabilities": 7572474000,
"non_operating_expenses": 17057062000,
"non_operating_income": 19617651000,
"operating_profit": -12897641000,
"revenue": 5754646000,
"sga_expenses": 14439370000,
"total_assets": 75937857000,
"total_equity": 39262943000,
"total_liabilities": 36674914000
},
"2023": {
"capital_stock": 10761939000,
"cost_of_sales": 4122476000,
"current_assets": 57558298000,
"current_liabilities": 50949354000,
"gross_profit": 1076719000,
"net_income": -13418958000,
"net_income_bs": -13418957000,
"non_current_assets": 42257764000,
"non_current_liabilities": 17669450000,
"non_operating_expenses": 10321029000,
"non_operating_income": 9625870000,
"operating_profit": -12723799000,
"revenue": 5199194000,
"sga_expenses": 13800518000,
"total_assets": 99816062000,
"total_equity": 31197257000,
"total_liabilities": 68618804000
},
"2024": {
"capital_stock": 10773414000,
"cost_of_sales": 2741791000,
"current_assets": 23336683000,
"current_liabilities": 37245139000,
"gross_profit": 2131937000,
"net_income": -10958366000,
"net_income_bs": -10958366000,
"non_current_assets": 52152264000,
"non_current_liabilities": 17312335000,
"non_operating_expenses": 11101154000,
"non_operating_income": 13438406000,
"operating_profit": -13295618000,
"revenue": 4873728000,
"sga_expenses": 15427555000,
"total_assets": 75488947000,
"total_equity": 20931474000,
"total_liabilities": 54557473000
}
},
"industry": "그 외 기타 분류 안된 화학제품 제조업",
"investment": [
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2024-08-05"
},
{
"amount": "8,474,000,000",
"changes": "8,474,000,000",
"date": "2021-08-06"
},
{
"amount": "1,207,931,000",
"changes": "1,207,931,000",
"date": "2016-02-19"
}
],
"phone": "031-431-****",
"source": "pg_migration"
}{
"address": "경기도 시흥시 마유로",
"brno": "140817****",
"cappedWarning": false,
"companyName": "주식회사티앤알바이오팹",
"estimatedAvgAnnualSalary": 49532220,
"estimatedAvgMonthlySalary": 4127685,
"fetchedAt": "2026-03-05T16:36:43.155Z",
"industryCode": "999999",
"industryName": "BIZ_NO미존재사업장",
"joinDate": "20130501",
"last12MonthsHired": 5,
"last12MonthsLeft": 3,
"last12MonthsNetChange": 2,
"leaveDate": null,
"monthlyPensionAmount": 32546800,
"monthlyTrend": [
{
"lostSubscribers": 3,
"newSubscribers": 5,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6436081",
"status": "1",
"styleCode": "1",
"subscriberCount": 83,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |